Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity.

Collectively, these results suggest that SEMA4D blockade may ameliorate disease pathology by preserving normal astrocyte function and reducing the negative consequences of reactive astrogliosis.